CORNEAL CONFOCAL MICROSCOPY AS AN EARLY DIAGNOSTIC TOOL FOR DIABETIC NEUROPATHY: A SYSTEMATIC REVIEW
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate the effectiveness of corneal confocal microscopy, its parameters, and threshold as an early diagnostic method for diabetic neuropathy
Method: A systematic review was conducted through PubMed, CENTRAL, and Scopus, searching for studies implementing corneal confocal microscopy (CCM) in patients with diabetes for detecting neuropathy in the early stage. Quality assessment of studies selected were performed using selected risk-of-bias assessment tool.
Results: The search yielded 9 studies with a total of 2027 subjects. From the 9 studies reviewed, CCM proved to be a reliable method of diagnosis for diabetic neuropathy with consistent sensitivity and specificity. Fiber length, density, and bead size are the most reliable parameters for diagnosis.
Conclusion: Significant correlation between CCM parameters and diabetic neuropathy were found. Therefore corneal confocal microscopy showed promising potentials as an early diagnostic tool for diabetic neuropathy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
© Journal of Asian Medical Students’ Association (JAMSA). Released under a Creative Commons license.
References
World Health Organization. Diabetes key facts [internet]. Geneva: World Health Organization. 2020 Jun 8 [cited 2020 Oct 27]. Available from: https://www.who.int/health-topics/diabetes#tab=tab_1
World Health Organization. Diabetes country profile: Indonesia [internet]. Geneva: World Health Organization. 2016 [cited 2020 Oct 27]. Available from: https://www.who.int/diabetes/country-profiles/idn_en.pdf?ua=1
World Health Organization. Global report on diabetes. Geneva: World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=B16DE065220ECE5E79D27F0DE7858A5C?sequence=1
Picon AP, Ortega NRS, Watari R, Sartor C, Sacco ICN. Classification of the severity of diabetic neuropathy: a new approach taking uncertainties into account using fuzzy logic. Clinics. 2012;67(2):151-6.
Petropoulos IN, Ponirakis G, Khan A, Almuhannadi H, Gad H, Malik RA. Diagnosing diabetic neuropathy: something old, something new. Diabetes Metab J. 2018 Aug;42(4):255-269.
Dy SM, Bennett WL, Sharma R, et al. Preventing complications and treating symptoms of diabetic peripheral neuropathy [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2017 Mar [cited 2020 Oct 28].Available from: https://www.ncbi.nlm.nih.gov/books/NBK442324/
Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019 Aug 27;19(10):86.
Won JC, Park TS. Recent advances in diagnostic strategies for diabetic peripheral neuropathy. Endocrinol Metab. 2016 Jun;31(2):230-8.
Pritchard N, Edwards K, Shahidi AM, Sampson GP, Russell AW, Malik RA, et al. Corneal markers of diabetic neuropathy. The Ocular Surface. 2011 Jan;9(1):17–28.
Azmi S, Petropoulos IN, Ferdousi M, Ponirakis G, Alam U, Malik RA. An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy. F1000Res [Internet]. 2019 Feb 15 [cited 2020 Oct 27];8:186. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381801/
Kane NM, Oware A. Nerve conduction and electromyography studies. Journal of Neurology. 2012;259(7):1502–1508.
DCCT Research Group. Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol. 1995;38:869–880.
Edwards K, Pritchard N, Vagenas D, Russel A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95:348-354.
Tavakoli M, Hossain P, Malik RA. Clinical applications of corneal confocal microscopy. Clin Ophthalmol. 2008 Jun;2(2):435-45.
Nguyen HT, Nieuwenhoff M, Dorrestijn N, Huygen FJPM, Niehof SP, Hay JL, et al. Good inter-center reproducibility of quantification of the corneal subbasal nerve plexus using in vivo corneal confocal microscopy. Invest Ophthalmol Vis Sci. 2016;57(12):1921.
Zafar S, Sachdeva M, Frankfort BJ, Channa R. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies. Curr Diab Rep. 2019 Feb 26;19(4):17. doi: 10.1007/s11892-019-1134-5. PMID: 30806815; PMCID: PMC7192364.
Hafner J, Zadrazil M, Grisold A, Ricken G, Krenn M, Kitzmantl D, et al. Retinal and corneal neurodegeneration and its association to systemic signs of peripheral neuropathy in type 2 diabetes. American Journal of Ophthalmology. 2019;209:197-205.
Andersen ST, Grosen K, Tankisi H, Charles M, Andersen NT, Andersen H, et al. Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark. J Diabetes Complications. 2018 Dec;32(12):1153-1159
Ziegler D, Winter K, Strom A, et al. Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes. PloS one. doi:10.1371/journal.pone.0173832.2017.03.15
Hertz P, Bril V, Orszag A, et al. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med. 2011;28(10):1253-1260.
Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95(3):348-354.
Yan A, Issar T, Tummanapalli SS, Markoulli M, Kwai NCG, Poynten AM, et al. Relationship between corneal confocal microscopy and markers of peripheral nerve structure and function in type 2 diabetes. Diabet Med. 2019; 37(2): 326-334.
Petropoulos IN, Alam U, Fadavi H, Asghar O, Green P, Ponirakis G et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. 2013; 36: 3646–3651.
Feldman EL, Nave KA, Jensen TS, Bennett DLH. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 2017; 93: 1296–1313.
Xiong Q, Lu B, Ye HY, Liu SY, Zheng HP, Zhang RY, et al. Corneal confocal microscopy as non-invasive test to assess diabetic peripheral neuropathy. Diabetic Research and Clinical Practice. 2017; 136: 85-92.
Ishibashi F, Kojima R, Taniguchi M, Kosaka A, Uetake H, Tavakoli M. The expanded bead size of corneal c-nerve fibers visualized by corneal confocal microscopy is associated with slow conduction velocity of the peripheral nerves in patients with type 2 diabetes mellitus. Journal of Diabetes Research. 2016 Aug 3;2016:1-9.
Ishibashi F, Kojima R, Taniguchi M, Kosaka A, Uetake H, Tavakoli M. The preferential impairment of pupil constriction stimulated by blue light in patients with type 2 diabetes without autonomic neuropathy. Journal of Diabetes Research. 2017;2017:1–11.
Dehghani C, Russell AW, Perkins BA, Malik RA, Pritchard N, Edwards K, et al. A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot. Journal of Diabetes and Its Complications. 2016;30(8):1437–1439.
Perkins BA, Lovblom LE, Bril V, Scarr D, Ostrovski I, Orszag A, et al (2018). Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia. 2018 Apr;61(8):1856–1861.
Tummanapalli SS, Issar T, Kwai N, Pisarcikova J, Poynten, Krishnan AV, et al. A comparative study on the diagnostic utility of corneal confocal microscopy and tear neuromediator levels in diabetic peripheral neuropathy. Curr Eye Res. 2019; 45(8): 921-930.
Taksande B, Ansari S, Jaikishan A, Karwasara V. The diagnostic sensitivity, specificity and reproducibility of the clinical physical examination signs in patients of diabetes mellitus for making diagnosis of peripheral neuropathy. Journal of Endocrinology and Metabolism. 2011;1(1):21-6.
Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications. 2007 Nov-Dec;21(6):353-8. doi: 10.1016/j.jdiacomp.2006.08.003. PMID: 17967706.